Shari S Rogal1, Daniel Winger, Klaus Bielefeldt, Eva Szigethy. 1. Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, 200 Lothrop Street, C Wing, M Level, PUH, Pittsburgh, PA, 15213, USA, rogalss@upmc.edu.
Abstract
BACKGROUND: Pain is common in patients with liver disease, difficult to treat, and poorly understood. AIMS: The aim of this study was to determine factors associated with pain and prescription opioid use in a large cohort of patients with confirmed chronic liver disease. METHODS: This was a retrospective cohort study of consecutive patients with chronic liver disease visiting a tertiary-care hepatology clinic. Pain was determined by self-report and rated numerically from 0 to 10. Symptoms of mood and sleep disorders and emotional distress were based on a symptom checklist. Etiology and stage of liver disease and use of prescribed opioids were abstracted from the electronic medical record. Logistic regression was used to establish factors associated with pain and prescription opioid use. RESULTS: Among 1,286 patients with chronic liver disease, 34 % had pain and 25 % used opioids. The strongest predictor of pain in multivariate modeling was emotional distress (OR 3.66, 95 % CI 2.40-5.64), followed by non-white race (OR 1.87, 95 % CI 1.24-2.79), mood symptoms (OR 1.47, 95 % CI 1.04-2.07), sleep disturbance/fatigue (OR 1.70, 95 % CI 1.24-2.32), and advanced liver disease (Child class B: OR 1.73, 95 % CI 1.15-2.60; Child class C: OR 2.78, 95 % CI 1.49-5.24) compared to no cirrhosis. Emotional distress, mood-related symptoms, and advanced liver disease were also significant predictors of prescription opioid use, as were age, nicotine use, and etiology of liver disease. CONCLUSIONS: This large cohort study demonstrates the high prevalence of pain and opioid use in chronic liver disease. While disease variables contribute to pain, psychological symptoms were most strongly associated with pain and opioid use, providing rationale and target for therapeutic interventions.
BACKGROUND:Pain is common in patients with liver disease, difficult to treat, and poorly understood. AIMS: The aim of this study was to determine factors associated with pain and prescription opioid use in a large cohort of patients with confirmed chronic liver disease. METHODS: This was a retrospective cohort study of consecutive patients with chronic liver disease visiting a tertiary-care hepatology clinic. Pain was determined by self-report and rated numerically from 0 to 10. Symptoms of mood and sleep disorders and emotional distress were based on a symptom checklist. Etiology and stage of liver disease and use of prescribed opioids were abstracted from the electronic medical record. Logistic regression was used to establish factors associated with pain and prescription opioid use. RESULTS: Among 1,286 patients with chronic liver disease, 34 % had pain and 25 % used opioids. The strongest predictor of pain in multivariate modeling was emotional distress (OR 3.66, 95 % CI 2.40-5.64), followed by non-white race (OR 1.87, 95 % CI 1.24-2.79), mood symptoms (OR 1.47, 95 % CI 1.04-2.07), sleep disturbance/fatigue (OR 1.70, 95 % CI 1.24-2.32), and advanced liver disease (Child class B: OR 1.73, 95 % CI 1.15-2.60; Child class C: OR 2.78, 95 % CI 1.49-5.24) compared to no cirrhosis. Emotional distress, mood-related symptoms, and advanced liver disease were also significant predictors of prescription opioid use, as were age, nicotine use, and etiology of liver disease. CONCLUSIONS: This large cohort study demonstrates the high prevalence of pain and opioid use in chronic liver disease. While disease variables contribute to pain, psychological symptoms were most strongly associated with pain and opioid use, providing rationale and target for therapeutic interventions.
Authors: Gordon G Liu; Marco daCosta DiBonaventura; Yong Yuan; Jan-Samuel Wagner; Gilbert J L'Italien; Paul Langley; Isao Kamae Journal: Value Health Date: 2012 Jan-Feb Impact factor: 5.725
Authors: J S Bajaj; L R Thacker; J B Wade; A J Sanyal; D M Heuman; R K Sterling; D P Gibson; R T Stravitz; P Puri; M Fuchs; V Luketic; N Noble; M White; D Bell; D A Revicki Journal: Aliment Pharmacol Ther Date: 2011-09-19 Impact factor: 8.171
Authors: Declan T Barry; Joseph L Goulet; Robert K Kerns; William C Becker; Adam J Gordon; Amy C Justice; David A Fiellin Journal: Pain Date: 2011-02-26 Impact factor: 6.961
Authors: Henry P Parkman; Katherine Yates; William L Hasler; Linda Nguyen; Pankaj J Pasricha; William J Snape; Gianrico Farrugia; Kenneth L Koch; Jorge Calles; Thomas L Abell; Richard W McCallum; Linda Lee; Aynur Unalp-Arida; James Tonascia; Frank Hamilton Journal: Clin Gastroenterol Hepatol Date: 2011-08-24 Impact factor: 11.382
Authors: Barry J A Laird; Angela C Scott; Lesley A Colvin; Amy-Louise McKeon; Gordon D Murray; Kenneth C H Fearon; Marie T Fallon Journal: J Pain Symptom Manage Date: 2011-03-12 Impact factor: 3.612
Authors: Benjamin J Morasco; Marilyn Huckans; Jennifer M Loftis; Jonathan Woodhouse; Adriana Seelye; Dennis C Turk; Peter Hauser Journal: Gen Hosp Psychiatry Date: 2010-04-27 Impact factor: 3.238
Authors: Kate M Dunn; Kathleen W Saunders; Carolyn M Rutter; Caleb J Banta-Green; Joseph O Merrill; Mark D Sullivan; Constance M Weisner; Michael J Silverberg; Cynthia I Campbell; Bruce M Psaty; Michael Von Korff Journal: Ann Intern Med Date: 2010-01-19 Impact factor: 25.391
Authors: Meredith Noble; Jonathan R Treadwell; Stephen J Tregear; Vivian H Coates; Philip J Wiffen; Clarisse Akafomo; Karen M Schoelles Journal: Cochrane Database Syst Rev Date: 2010-01-20
Authors: Shari S Rogal; Klaus Bielefeldt; Ajay D Wasan; Eva Szigethy; Francis Lotrich; Andrea F DiMartini Journal: Dig Dis Sci Date: 2014-11-30 Impact factor: 3.199
Authors: Shari S Rogal; Klaus Bielefeldt; Ajay D Wasan; Francis E Lotrich; Susan Zickmund; Eva Szigethy; Andrea F DiMartini Journal: Clin Gastroenterol Hepatol Date: 2014-11-05 Impact factor: 11.382
Authors: Jessica B Rubin; Jennifer C Lai; Amy M Shui; Samuel F Hohmann; Andrew Auerbach Journal: J Clin Gastroenterol Date: 2021-10-14 Impact factor: 3.062
Authors: Shari S Rogal; Matthew J Chinman; William DeMonte; Sandra Gibson; Stephanie Hoyt-Trapp; Gloria J Klima; Naudia L Jonassaint; Jane M Liebschutz; Kevin L Kraemer; Jessica Merlin Journal: Dig Dis Sci Date: 2022-02-11 Impact factor: 3.487
Authors: Andrew M Moon; Yue Jiang; Shari S Rogal; Elliot B Tapper; Sarah R Lieber; A Sidney Barritt Journal: Aliment Pharmacol Ther Date: 2020-01-21 Impact factor: 8.171
Authors: Shari S Rogal; Lauren A Beste; Ada Youk; Michael J Fine; Bryan Ketterer; Hongwei Zhang; Steven Leipertz; Maggie Chartier; Chester B Good; Kevin L Kraemer; Matthew Chinman; Timothy Morgan; Walid F Gellad Journal: Clin Gastroenterol Hepatol Date: 2018-10-17 Impact factor: 11.382
Authors: Andrew M Moon; Stephanie E Watkins; Anna S Lok; Roberto J Firpi-Morell; Huy Ngoc Trinh; Justin T Kupec; Cheryl Schoen; Brent A Neuschwander-Tetri; A Sidney Barritt Journal: Dig Dis Date: 2020-08-24 Impact factor: 2.404